
Redox vs Direct EHR Integration
Use Redox, or a similar integration platform, to reach many health systems fast through one normalized API in exchange for platform fees. Integrate directly when you have a few high-value EHR targets, need data the platform doesn't expose, or fees outweigh the engineering saved.
What is the difference between Redox and direct integration?
Quick answer
Redox vs direct integration is a choice between one integration platform and building to each EHR yourself. Redox gives you one normalized API and existing connections, so you can reach many health systems sooner for platform fees. Direct integration means more engineering per connection, but full control of data access, write operations and cost at volume.
| Criterion | Redox | Direct |
|---|---|---|
| Time to first integration | Fast | Slower (build per connection) |
| Coverage / reach | Broad managed network | Only what you build |
| Standards handled | Platform maps FHIR and HL7 v2 behind one data model | You build to each EHR's FHIR, HL7 v2 or proprietary API |
| Cost model | Platform + usage fees | Engineering + maintenance |
| Control & data access | Normalized (some abstraction) | Full, raw access |
| Parties in the PHI path | Platform is a business associate (BAA needed) | One fewer third party |
| Ops burden | Largely on the platform | On you |
| Best at scale | Many shallow connections | Few deep connections |
What are Redox and direct EHR integration?
What is Redox
Redox is a healthcare integration platform that sits between your app and health systems. It offers one normalized API and a managed network of existing connections instead of a build to each EHR, and runs much of the interface plumbing as a service.
What is Direct
Direct integration means building straight to each EHR's APIs (FHIR, proprietary) or interfaces (HL7 v2) yourself. You own every connection end to end: more engineering and maintenance, but full control of capabilities, data access, and cost per connection.
Redox vs direct integration pros and cons
Coverage and speed vs cost
A platform's core value is reach and speed: you can sign a new health-system customer without a fresh interface project. That speed carries platform and usage fees that scale with connections and volume. Direct integration front-loads engineering but has no per-connection platform fee afterward.
Control and data fidelity
Normalization cuts both ways. One clean API is convenient, but abstraction can hide or reshape data you need, and platform capabilities lag raw EHR APIs at the edges. Direct integration gives you the full data contract, including fields and write operations the platform doesn't surface.
Operational responsibility
With Redox, connection monitoring, health-system changes and much interface upkeep are the vendor's job. Direct integration means you own uptime, versioning and every EHR's quirks. Lean teams often find the fees worth it; a team with integration expertise and few targets may not.
Economics flip with your integration shape
The honest rule of thumb: many shallow connections favor a platform; a few deep, high-volume connections favor direct. Map your pipeline (breadth of health systems, depth per system, and transaction volume) against platform pricing to find where the lines cross.
When should you choose Redox or direct integration?
When to use Redox (Integration Platform)
- You need to connect to many health systems quickly across a sales pipeline.
- You want one API surface instead of maintaining N bespoke EHR interfaces.
- You'd rather pay platform fees than staff an interface/integration team.
- You value the platform's existing connections and reduced time-to-first-integration.
When to use Direct EHR Integration
- You have a small set of high-value EHR targets to integrate deeply.
- You need data or write capabilities the platform doesn't expose or normalizes away.
- Platform fees at your transaction/volume level exceed the cost of building direct.
- You require full control over latency, error handling, and the data contract.
Can you use Redox and direct integration together?
Redox and direct integration aren't mutually exclusive. A common pattern uses Redox to onboard the long tail of health systems quickly and builds direct integrations for the largest accounts, where volume makes fees expensive or the platform hides needed capabilities.
Design your internal integration layer so the source (platform vs direct) is an implementation detail behind a stable domain model. That lets you move an account from platform to direct later without rewriting the app, and keeps your options open as economics and requirements evolve.
Which sources does this comparison rely on?
- ONC certification criterion 45 CFR 170.315(g)(10) requires certified health IT to offer a standardized API for patient and population services (eCFR)
- 45 CFR 170.215 adopts HL7 FHIR Release 4.0.1 as the API base standard for certified health IT, with US Core and the SMART App Launch framework as implementation specifications (eCFR)
- A covered entity may let a business associate, such as an integration platform, create, receive, maintain or transmit protected health information only after obtaining satisfactory assurance that it will safeguard the information (45 CFR 164.502(e), eCFR)
- The HIPAA Security Rule requires technical measures to guard against unauthorized access to electronic protected health information sent over an electronic communications network (45 CFR 164.312(e)(1), eCFR)
Frequently Asked Questions
Not sure which fits your build?
Tell us about your product, integration targets, and timeline. We'll map the trade-offs to your context and recommend the path that gets you to a compliant launch fastest.